Literature DB >> 20599726

Heterogeneous antigen recognition behavior of induced polyspecific antibodies.

Jordan D Dimitrov1, Cyril Planchais, Jonghoon Kang, Anastas Pashov, Tchavdar L Vassilev, Srinivas V Kaveri, Sebastien Lacroix-Desmazes.   

Abstract

Polyspecific antibodies represent a significant fraction of the antibody repertoires in healthy animals and humans. Interestingly, certain antibodies only acquire a polyspecific antigen-binding behavior after exposure to protein-modifying conditions, such as those found at inflammation sites, or used in small- and large-scale immunoglobulin purification. This phenomenon is referred to as "criptic polyspecificity". In the present study, we compare the potential of different chemical agents to induce IgG polyspecificity. Depending on the treatment used, quantitative and qualitative differences in the recognition of individual antigens from a standard panel were observed. Antibodies with cryptic polyspecificity utilized common mechanisms for the recognition of structurally unrelated antigens when exposed to a particular inductor of polyspecificity. Our study contributes to the understanding of the mechanisms underlying the cryptic polyspecificity. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599726     DOI: 10.1016/j.bbrc.2010.06.073

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Heme-Exposed Pooled Therapeutic IgG Improves Endotoxemia Survival.

Authors:  Iglika Djoumerska-Alexieva; Lubka T Roumenina; Tsvetanka Stefanova; Tchavdar Vassilev; Jordan D Dimitrov
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

2.  Autoimmune reactivity of IgM acquired after oxidation.

Authors:  Jasna Omersel; Ivica Avberšek-Lužnik; Pegi Ahlin Grabnar; Tanja Kveder; Blaž Rozman; Borut Božič
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

3.  A cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanism.

Authors:  Jordan D Dimitrov; Cyril Planchais; Tobias Scheel; Delphine Ohayon; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

4.  Physical characterization of the "immunosignaturing effect".

Authors:  Phillip Stafford; Rebecca Halperin; Joseph Bart Legutki; Dewey Mitchell Magee; John Galgiani; Stephen Albert Johnston
Journal:  Mol Cell Proteomics       Date:  2012-01-18       Impact factor: 5.911

5.  Binding of plasma proteins to titanium dioxide nanotubes with different diameters.

Authors:  Mukta Kulkarni; Ajda Flašker; Maruša Lokar; Katjuša Mrak-Poljšak; Anca Mazare; Andrej Artenjak; Saša Čučnik; Slavko Kralj; Aljaž Velikonja; Patrik Schmuki; Veronika Kralj-Iglič; Snezna Sodin-Semrl; Aleš Iglič
Journal:  Int J Nanomedicine       Date:  2015-02-18

Review 6.  Modelling of pH-dependence to develop a strategy for stabilising mAbs at acidic steps in production.

Authors:  Max Hebditch; Ryan Kean; Jim Warwicker
Journal:  Comput Struct Biotechnol J       Date:  2020-03-10       Impact factor: 7.271

7.  Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents.

Authors:  Maxime Lecerf; Robin Lacombe; Alexia Kanyavuz; Jordan D Dimitrov
Journal:  Antibodies (Basel)       Date:  2022-02-02

8.  Confirmatory detection of neutralizing antibodies to AAV gene therapy using a cell-based transduction inhibition assay.

Authors:  Theresa Kasprzyk; Sabrina Triffault; Brian R Long; Stephen J Zoog; Christian Vettermann
Journal:  Mol Ther Methods Clin Dev       Date:  2022-01-07       Impact factor: 6.698

9.  Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.

Authors:  Susann Cattepoel; Annette Gaida; Alain Kropf; Marc W Nolte; Reinhard Bolli; Sylvia M Miescher
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.